Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.635 USD | -0.67% | +24.29% | +15.16% |
Apr. 17 | IGM Biosciences, Sanofi Narrow Partnership to Focus on Potential Immunology and Inflamation Targets | MT |
Apr. 17 | IGM Biosciences, Inc. Announces Refocusing of Sanofi Collaboration | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.16% | 572M | |
-3.18% | 102B | |
+1.69% | 96.29B | |
+2.13% | 22.18B | |
-15.61% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-15.24% | 16.36B | |
+5.06% | 13.97B | |
+33.30% | 12.17B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating